Anti-pyretic
Showing 1 - 25 of >10,000
Thrombocytopenia Trial in Karachi (Karika Syrup)
Recruiting
- Thrombocytopenia
- Karika Syrup
-
Karachi, Sindh, PakistanPakistan
Oct 1, 2022
Meningococcal Vaccine Trial in Worldwide (MenABCWY, Saline, rLP2086)
Completed
- Meningococcal Vaccine
- MenABCWY
- +3 more
-
Birmingham, Alabama
- +68 more
Jan 23, 2023
Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation Trial (Allogenic
Not yet recruiting
- Refractory Idiopathic Aplastic Anemia
- Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
- Allogenic transplantation
- (no location specified)
Nov 8, 2021
Covid19 Trial in Karachi (Anti COVID 19 Intravenous Immunoglobulin (C-IVIG))
Recruiting
- Covid19
- Anti COVID 19 Intravenous Immunoglobulin (C-IVIG)
-
Karachi, Sindh, PakistanDow University of Health Sciences
Aug 17, 2021
Postoperative Pain, IVF Trial in Manhasset (acetaminophen)
Suspended
- Postoperative Pain
- IVF
-
Manhasset, New YorkNorthwell Fertility Center #3816
Jul 8, 2021
Bronchiolitis, Viral Trial in Pittsburgh (Placebos, Dexamethasone Oral)
Suspended
- Bronchiolitis, Viral
- Placebos
- Dexamethasone Oral
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Apr 7, 2021
Hematologic Diseases, Graft Failure, Allogeneic Hematopoietic Stem Cell Transplantation Trial (haplo-SCT with PTCy)
Not yet recruiting
- Hematologic Diseases
- +2 more
- haplo-SCT with PTCy
- (no location specified)
Nov 8, 2021
Exertional Dyspnea and Exercise Intolerance in COVID-19
Active, not recruiting
- Covid19
- Dyspnea
- No Intervention
-
Edmonton, Alberta, CanadaClinical Physiology Laboratory
Dec 5, 2022
Diagnostic Score for Encephalitis to Assess Risk of Autoimmune
Recruiting
- Autoimmune Encephalitis
- Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
- Clinical score of Granillo and al.
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Jul 12, 2023
Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19
Completed
- Critical Illness
- +2 more
- blood sampling
-
Arnhem, NetherlandsMonique de Maat
Jun 28, 2023
Seasonal Allergic Rhinitis Trial in China (LP-003 dose 1, LP-003 dose 2, Placebo)
Recruiting
- Seasonal Allergic Rhinitis
- LP-003 dose 1
- +2 more
-
Beijing, Beijing, China
- +16 more
Sep 18, 2023
NSCLC Trial in Beijing, Tianjin (TQB2450 injection, docetaxel injection matching , AL2846 capsules, TQB2450 matching , docetaxel
Recruiting
- Non-small Cell Lung Cancer
- TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules
- TQB2450 matching placebo, docetaxel injection, AL2846 matching placebo
-
Beijing, Beijing, China
- +2 more
Jun 19, 2023
Technology Trial in Hong Kong (The anti-wandering system)
Not yet recruiting
- Technology
- The anti-wandering system
-
Hong Kong, Hong KongHaven of Hope Residential Service for the Disabled
Mar 28, 2023
Celiac Disease Trial in Spain
Recruiting
- Celiac Disease
-
Terrassa, Barcelona, Spain
- +5 more
Aug 10, 2023
Thyroid Diseases, Hypothyroidism, Hashimoto Disease Trial in Tehran (curcumin, Anti-inflammatory diet)
Not yet recruiting
- Thyroid Diseases
- +2 more
- curcumin
- Anti-inflammatory diet
-
Tehran, National Nutrition And Food Technology Research Institute, Iran, Islamic Republic ofGolbon Sohrab
Jul 27, 2023
Post-endodontic Pain Trial in Cairo (Cryotherapy, Diclofenac sodium, Dexamethasone sodium phosphate)
Recruiting
- Post-endodontic Pain
- Cryotherapy
- +2 more
-
Cairo, EgyptAin Shams University
Oct 13, 2023
Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell
Not yet recruiting
- Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
- +2 more
- Biopsy
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 28, 2023
T- and B-Cell Subpopulations in Membranous Nephropathy
Recruiting
- Membranous Nephropathy
- +2 more
-
Istanbul, TurkeyIstanbul University
May 31, 2023
Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult Trial in Germany (IMA402 (Phase Ia), IMA402 (Phase Ib), IMA402 (Phase
Not yet recruiting
- Refractory Cancer
- +3 more
- IMA402 (Phase Ia)
- +2 more
-
Heidelberg, Baden-Wuerttemberg, Germany
- +12 more
Jul 14, 2023
HER2-positive Gastric Cancer, Immunotherapy Trial in Shanghai (Disitamab Vedotin combined with fruquintinib and Tislelizumab)
Recruiting
- HER2-positive Gastric Cancer
- Immunotherapy
- Disitamab Vedotin combined with fruquintinib and Tislelizumab
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 8, 2023
Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)
Not yet recruiting
- Locally Advanced Rectal Cancer
- AK104
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 5, 2023
Ulcerative Colitis Trial ("Mesalamine" and "alpha-lipoic acid", "Mesalamine" and "Placebo")
Not yet recruiting
- Ulcerative Colitis
- "Mesalamine" and "alpha-lipoic acid"
- "Mesalamine" and "Placebo"
- (no location specified)
Oct 5, 2023
COVID-19, SARS-CoV 2 Trial in United States (Hydroxychloroquine (HCQ), Azithromycin (Azithro), Placebo for Hydroxychloroquine)
Terminated
- COVID-19
- SARS-CoV 2
- Hydroxychloroquine (HCQ)
- +3 more
-
Birmingham, Alabama
- +10 more
Nov 12, 2021
Wrinkle, Spot Pigmented, Lines Skin Trial in Clearwater (Nutraceutical Topical)
Recruiting
- Wrinkle
- +2 more
- Nutraceutical Topical
-
Clearwater, FloridaLaser Scalp and Hair Center
Feb 9, 2023